Basilea Pharmaceutica

Basilea is a commercial-stage biopharmaceutical company headquartered in Switzerland. It is dedicated to the discovery, development, and commercialization of innovative drugs to address the medical needs of patients with cancer and infectious diseases. The company has successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for severe bacterial infections. Basilea is currently conducting clinical studies with two targeted drug candidates for the treatment of various cancers and holds numerous preclinical assets for cancer and infectious diseases in its portfolio.